Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis (Q37315305)

19 August 2017

1 reference

title

Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis (English)

1 reference

cost-effectiveness analysis

19 August 2017

main subject

1 reference

Scott D Grosse

1 reference

19 August 2017

Sarah Wordsworth

series ordinal

1 reference

19 August 2017

Katherine Payne

series ordinal

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

648-654

1 reference

Outcome measurement in clinical genetics services: a systematic review of validated measures.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

The Use of Gene Tests to Detect Hereditary Predisposition to Chronic Disease: Is Cost-Effectiveness Analysis Relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

What is the clinical utility of genetic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Genetic test evaluation: information needs of clinicians, policy makers, and the public

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Willingness to pay methods in health care: a sceptical view

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Lessons from cost-effectiveness research for United States public health policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Is economic evaluation in touch with society's health values?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Equity versus efficiency: a dilemma for the NHS. If the NHS is serious about equity it must offer guidance when principles conflict

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Economic evaluation and decision making in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Costeffectiveness of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Preference-based measures in economic evaluation in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Cost utility of prenatal diagnosis and the risk-based threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Cost-effectiveness analysis of prenatal population-based fragile X carrier screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Implications of spillover effects within the family for medical cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Incorporation of process preferences within the QALY framework: a study of alternative methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Cost effectiveness analysis in health care: contraindications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Willingness to pay: a valid and reliable measure of health state preference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Genetic health technology and economic evaluation: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

21 January 2018

What Do Patients Value?

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Changing perspectives on the benefits of newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Construction of the contingent valuation market in health care: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Contingent valuation in health care: does it matter how the 'good' is described?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Economic considerations for health insurance coverage of emerging genetic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Economic analyses of human genetics services: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Genetic screening by DNA technology: a systematic review of health economic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

The value of diagnostic information to patients with suspected multiple sclerosis. Rochester-Toronto MRI Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

What do we tell the children? Contrasting the disclosure choices of two HD families regarding risk status and predictive genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Economic evaluation of prenatal diagnosis: a methodological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Measuring patient preferences for colorectal cancer screening using a choice-format survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Improving Service Evaluation in Clinical Genetics: Identifying Effects of Genetic Diseases on Individuals and Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Outcome measures for clinical genetics services: A comparison of genetics healthcare professionals and patients’ views

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Knowing for the sake of knowing: the value of prognostic information

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

Decision Making with Respect to Diagnostic Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181837217

10.1097/GIM.0B013E3181837217

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1005331293

0 references

Fatcat ID

release_mzeeruiy2bb6hp3un4k3rx67ya

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mzeeruiy2bb6hp3un4k3rx67ya

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference